The development of inhibitors for the infection using phage library

利用噬菌体库开发感染抑制剂

• 批准号: 14380411
• 负责人: SATO Toshinori
• 金额: $ 5.18万
• 依托单位: Keio University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 2002
• 资助国家: 日本
• 起止时间: 2002 至 2004
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-14380411/
• 关键词: Phage Library; Peptide; Carbohydrate recognition; Influenza virus; Inhibitor; Hemagglutinin; Molecular evolution; Liposome; インフルエンザウィルス; 分子進化法; ファージライブラリー法; 糖脂質; 感染阻害剤

Influenza HA is known to bind sialylgalactoside having α2-3- or α2-6- linkages on host cells at the first step of infection. We attempted to design peptides as a universal inhibitor that bind to the receptor-binding pocket of HA.In order to obtain peptides which are a mimic of sialyl oligosaccharide, a phage-displayed random pentadecapeptide library have been employed. phage-displayed method is a selection technology using a pool of phage. It was expected that HA-binding peptides selected from the phage library would serve as inhibitors of influenza A virus. In this study, the HA-binding peptides and glycolipid-binding peptides were selected from the phage-displayed peptide libraries, and they inhibited the infection of both HA1 and HA3 subtypes of influenza virus to MDCK cells. Although the theoretical molecular diversity of pentadecapeptide is calculated to be 3.3x10^<19>, the phage library employed has only 2.5x10^8 kinds of diversity. Therefore, in order to obtain improved the HA-binding peptides, sublibrary generated from a selected sequence was prepared. The directed evolution approach was employed to prepare the sublibraries.The two kinds of sublibraries were constructed to obtain HA1- and HA3-binding peptides. Through the affinity selections for HA1 and HA3 using the sublibraries, several peptide sequences having mutations were obtained. Many of the mutant phage clones showed higher binding affinity for both HA1 and HA3 subtypes than the original A-1 phage. The evoluted peptides inhibited the infection of influenza virus to MDCK cells more efficiently than the original A-1 peptide.

已知流感 HA 在感染的第一步与宿主细胞上具有 α2-3- 或 α2-6- 连接的唾液酸半乳糖苷结合，我们尝试设计肽作为与 HA 受体结合口袋结合的通用抑制剂。为了获得唾液酸寡糖的模拟肽，采用噬菌体展示随机十五肽文库进行选择。预期从噬菌体库中选择的HA结合肽将作为甲型流感病毒的抑制剂。在本研究中，HA结合肽和糖脂结合肽是从噬菌体展示中选择的。尽管十五肽的理论分子多样性计算为： 3.3x10^19>，所使用的噬菌体文库仅具有2.5x10^8种多样性，因此，为了获得改进的HA结合肽，采用定向进化方法来制备从选定序列生成的子文库。准备子文库。通过使用HA1和HA3的亲和力选择来构建两种子文库以获得HA1和HA3结合肽。在子文库中，许多突变噬菌体克隆对HA1和HA3亚型均表现出比原始A-1噬菌体更高的结合亲和力。进化的肽比原始噬菌体更有效地抑制流感病毒对MDCK细胞的感染。原始A-1肽。

项目成果

インフルエンザウイルス感染抑制剤

流感病毒感染抑制剂

• 发表时间: 2004

Inhibition of Influenza Virus Infection by Hemagglutinin-Binding Peptides

血凝素结合肽抑制流感病毒感染

• 发表时间: 2002
• 期刊: Peptide Science 2001
• 作者: T.Sato;M.Sumi;K.Ogino;T.Taki
• 通讯作者: T.Taki

ヘマグルチニン結合ペプチド

血凝素结合肽

• 发表时间: 2004

T.Sato et al.: "Inhibition of Influenza Virus Infection by Hemagglutinin-Binding Peputides"Peptide Science 2001. 329-330 (2002)

T.Sato 等人：“血凝素结合肽对流感病毒感染的抑制”肽科学 2001. 329-330 (2002)

佐藤 智典: "グライコーム"化学フロンティア. 171-179 (2002)

Tomonori Sato：“Glycome”化学前沿 171-179 (2002)